Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
OPERATING ACTIVITIES
Net income (loss)	$ (437.5)	$ 513.4	$ 388.6
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Impairment, restructuring and other	666.8	0.0	0.0
Costs related to refinancing	0.0	0.0	15.1
Share-based compensation expense	34.3	40.6	57.9
Depreciation	68.1	62.9	62.2
Amortization	37.1	30.9	32.5
Deferred taxes	(182.8)	22.5	(11.1)
Equity in (income) loss of unconsolidated affiliates, net of distributions	12.9	(2.6)	0.0
Other, net	1.1	(10.8)	4.2
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	102.8	15.5	(188.1)
Inventories	(203.8)	(496.5)	(80.6)
Prepaid and other assets	(3.3)	(76.5)	(19.4)
Accounts payable	(171.2)	202.5	172.2
Other current liabilities	(68.4)	(21.6)	148.6
Other non-current items	20.1	(10.1)	(24.8)
Other, net	(5.2)	1.3	0.7
Net cash (used in) provided by operating activities	(129.0)	271.5	558.0
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets	63.3	0.2	0.4
Investments in property, plant and equipment	(113.5)	(106.9)	(62.7)
Investments in loans receivable	0.0	0.0	(3.4)
Proceeds from sale of brand extension assets	0.0	0.0	115.5
Investments in unconsolidated affiliates	0.0	(102.3)	0.0
Payment for acquisitions, net of cash acquired	(237.3)	(127.8)	0.0
Purchase of convertible debt investments	(25.0)	(193.1)	0.0
Other investing, net	29.3	(8.7)	(2.9)
Net cash (used in) provided by investing activities	(283.2)	(538.6)	46.9
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans	3,617.4	1,243.2	1,222.7
Repayments under revolving and bank lines of credit and term loans	(2,937.3)	(1,361.5)	(1,413.8)
Financing and issuance fees	(9.6)	(13.1)	(18.7)
Dividends paid	(166.2)	(143.0)	(411.2)
Purchase of Common Shares	(257.9)	(129.3)	(53.2)
Payments on seller notes	0.0	0.0	(0.5)
Cash received from exercise of stock options	3.3	15.2	17.6
Acquisition of noncontrolling interests	0.0	(17.5)	0.0
Other financing, net	5.6	0.0	0.0
Net cash provided by (used in) financing activities	255.3	494.0	(607.1)
Effect of exchange rate changes on cash	(0.4)	0.6	0.0
Net increase (decrease) in cash and cash equivalents	(157.3)	227.5	(2.2)
Cash and cash equivalents at beginning of year	244.1	16.6	18.8
Cash and cash equivalents at end of year	86.8	244.1	16.6
Senior Notes due 2031 – 4.000%
FINANCING ACTIVITIES
Proceeds from Issuance of Senior Notes	0.0	500.0	0.0
Senior Notes due 2032 – 4.375%
FINANCING ACTIVITIES
Proceeds from Issuance of Senior Notes	0.0	400.0	0.0
4.500% Senior Notes
FINANCING ACTIVITIES
Proceeds from Issuance of Senior Notes	0.0	0.0	450.0
6.000% Senior Notes
FINANCING ACTIVITIES
Repayment of Senior Notes	$ 0.0	$ 0.0	$ (400.0)